|
22 Stars |
Source: DGNews | Posted 44 weeks agoPrognostic Ability of Scoring System for NSCLC Second-Line Therapy ValidatedTags: |
Meeting: WCLC
-
-
19Stars
Source: DGNews | Posted 44 weeks ago
Never-Smokers With Adenocarcinoma Benefit From Bevacizumab Plus Erlotinib
Tags:
-
23Stars
Source: DGNews | Posted 44 weeks ago
Crizotinib Provides Clinically Meaningful Antitumour Activity in Patients With ALK-Positive Lung Cancer
Tags:
-
14Stars
Source: DGNews | Posted 44 weeks ago
Researchers Identify DNA Response Marker for Non-Small-Cell Lung Cancer
-
20Stars
Source: DGNews | Posted 44 weeks ago
Higher Levels of ER-alpha mRNA Associated With Better Overall Survival in NSCLC
Tags:
-
14Stars
Source: DGNews | Posted 44 weeks ago
Stereotactic Ablative Radiotherapy a Good Treatment Option for Elderly Patients With Lung Cancer
Tags:
-
11Stars
Source: DGNews | Posted 44 weeks ago
Erlotinib Doubles Progression-Free Survival in Western Patients With NSCLC
Tags:
-
31Stars
Source: DGNews | Posted 44 weeks ago
Erlotinib Noninferior to Docetaxel or Pemetrexed as Second-Line Therapy for Advanced NSCLC
-
19Stars
Source: DGNews | Posted 44 weeks ago
Maintenance With Pemetrexed After Induction Improves Survival in Patients With NSCLC
-
52Stars
Source: DGNews | Posted 45 weeks ago
Denosumab Prolongs Overall Survival in Patients With Lung Cancer